Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study. - Pratley, RE; Nauck, MA; Barnett, AH (Lancet Diabetes Endocrinol, 2014)
doi:10.1016/S2213-8587(13)70214-6